PC-NSAIDs: Gastrointestinal-safe and potent anti-inflammatory drugs

Award Information
Agency:
Department of Defense
Branch
Army
Amount:
$729,991.00
Award Year:
2008
Program:
SBIR
Phase:
Phase II
Contract:
W81XWH-08-C-0025
Agency Tracking Number:
A072-142-0602
Solicitation Year:
n/a
Solicitation Topic Code:
n/a
Solicitation Number:
n/a
Small Business Information
PLX PHARMA, INC.
8285 EL RIO, SUITE 130, HOUSTON, TX, 77054
Hubzone Owned:
N
Socially and Economically Disadvantaged:
N
Woman Owned:
N
Duns:
140243572
Principal Investigator:
Upendra Marathi
Senior Vice President
(713) 842-1249
marathi@plxpharma.com
Business Contact:
Ronald Zimmerman
President & CEO
(713) 842-1249
ron.zimmerman@plxpharma.com
Research Institution:
n/a
Abstract
We have developed a novel class of phosphatidylcholine (PC)-associated nonsteroidal antiinflammatory drugs (NSAIDs) to treat inflammation and pain with reduced GI side-effects. In Phase I studies using a number of in vitro systems monitoring the activity and threshold of nociceptive fibers under basal conditions and after exposure to inflammatory mediators, we demonstrated that a number of PC-NSAIDs were more effective than the unmodified drugs in reducing the activity of pain sensory nerves. Interestingly, preliminary analysis of in vitro primary human osteoblasts suggest that PC-NSAIDs may have favorable effects on bone remodeling compared with unmodified NSAIDs Based upon these studies, we propose to investigate in Phase II the therapeutic actions of the most effective PC-NSAID we have identified, Indomethacin-PC (vs. unmodified indomethacin) in rodent models of joint and nerve inflammation, post-operative incisional pain (to both mechanical and thermal stimulation) and bone healing. We also propose to evaluate the GI toxicity of the test NSAIDs in the above in vivo model systems to confirm Indomethacin-PC's superior GI safety. The parenteral and oral formulations of Indomethacin-PC will be optimized by the scientists at PLx Pharma in close consultation with our industrial advisors and our Co-investigators at the two University of Texas institutions.

* information listed above is at the time of submission.

Agency Micro-sites

US Flag An Official Website of the United States Government